Muscle Pharm Corp. Provides Earnings Outlook for the Full Year of 2013 and 2014
For the full year of 2014, the company reported that it expects to report net revenues of $150 million and earnings per share in the range of $0.20 to $0.22.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.92% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 33 | |
+191.37% | 6.97B | |
+5.09% | 1.04B | |
+2.10% | 982M | |
+41.91% | 872M | |
+24.45% | 814M | |
+11.31% | 675M | |
+1.72% | 664M | |
-.--% | 600M | |
+3.61% | 503M |